TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of the Effect of Two Different Types of Telephone Counselling Respectively and a Web-based Smoking Cessation Programme Among Adult Daily Cigarette Smokers.
Brief Summary: The primary objective of the study is to compare the efficacy of four different smoking cessation programmes, including a proactive telephone counseling intervention, a reactive telephone counseling a and an interactive web-based intervention and (as control) written self-help material.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Educational print materials and coaching call | Intervention Type: BEHAVIORAL; Name: Educational print materials and coaching call; Assigned to Arm(s): Intervention
B: Arm Label: Materials; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help materials | Arm Label: Telephone Counseling and Materials; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone counseling, Behavioral: Self-help materials | Intervention Type: BEHAVIORAL; Name: Telephone counseling; Assigned to Arm(s): Telephone Counseling and Materials | Intervention Type: BEHAVIORAL; Name: Self-help materials; Assigned to Arm(s): Materials, Telephone Counseling and Materials
C: Arm Label: Interactive Voice Response Group; Type: EXPERIMENTAL; Interventions: Behavioral: Interactive Voice Response | Arm Label: Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Interactive Voice Response; Assigned to Arm(s): Interactive Voice Response Group
D: Arm Label: Telephone counselling; Type: EXPERIMENTAL; Interventions: Device: Standard 15-minute telephone counselling, Device: Proactive telephone counselling | Arm Label: Proactive telephone counselling; Type: EXPERIMENTAL; Interventions: Device: Proactive telephone counselling | Arm Label: web-based smoking cessation programme; Type: EXPERIMENTAL; Interventions: Device: Interactive web-based smoking cessation programme | Arm Label: Self-help material; Type: ACTIVE_COMPARATOR; Interventions: Device: Self-help material | Intervention Type: DEVICE; Name: Standard 15-minute telephone counselling; Assigned to Arm(s): Telephone counselling | Intervention Type: DEVICE; Name: Proactive telephone counselling; Assigned to Arm(s): Proactive telephone counselling, Telephone counselling | Intervention Type: DEVICE; Name: Interactive web-based smoking cessation programme; Assigned to Arm(s): web-based smoking cessation programme | Intervention Type: DEVICE; Name: Self-help material; Assigned to Arm(s): Self-help material

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of the Effect of Two Different Types of Telephone Counselling Respectively and a Web-based Smoking Cessation Programme Among Adult Daily Cigarette Smokers.
Brief Summary: The primary objective of the study is to compare the efficacy of four different smoking cessation programmes, including a proactive telephone counseling intervention, a reactive telephone counseling a and an interactive web-based intervention and (as control) written self-help material.


Options:
A: Arm Label: Website A; Type: EXPERIMENTAL; Interventions: Behavioral: Website A | Arm Label: Website B; Type: OTHER; Interventions: Other: Website B | Intervention Type: BEHAVIORAL; Name: Website A; Assigned to Arm(s): Website A | Intervention Type: OTHER; Name: Website B; Assigned to Arm(s): Website B
B: Arm Label: WebQuit study group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WebQuit study group | Arm Label: WebQuit control group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: WebQuit control group | Intervention Type: BEHAVIORAL; Name: WebQuit study group; Assigned to Arm(s): WebQuit study group | Intervention Type: BEHAVIORAL; Name: WebQuit control group; Assigned to Arm(s): WebQuit control group
C: Arm Label: Telephone counselling; Type: EXPERIMENTAL; Interventions: Device: Standard 15-minute telephone counselling, Device: Proactive telephone counselling | Arm Label: Proactive telephone counselling; Type: EXPERIMENTAL; Interventions: Device: Proactive telephone counselling | Arm Label: web-based smoking cessation programme; Type: EXPERIMENTAL; Interventions: Device: Interactive web-based smoking cessation programme | Arm Label: Self-help material; Type: ACTIVE_COMPARATOR; Interventions: Device: Self-help material | Intervention Type: DEVICE; Name: Standard 15-minute telephone counselling; Assigned to Arm(s): Telephone counselling | Intervention Type: DEVICE; Name: Proactive telephone counselling; Assigned to Arm(s): Proactive telephone counselling, Telephone counselling | Intervention Type: DEVICE; Name: Interactive web-based smoking cessation programme; Assigned to Arm(s): web-based smoking cessation programme | Intervention Type: DEVICE; Name: Self-help material; Assigned to Arm(s): Self-help material
D: Intervention Type: BEHAVIORAL; Name: smoking cessation intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: internet-based intervention; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of the Effect of Two Different Types of Telephone Counselling Respectively and a Web-based Smoking Cessation Programme Among Adult Daily Cigarette Smokers.
Brief Summary: The primary objective of the study is to compare the efficacy of four different smoking cessation programmes, including a proactive telephone counseling intervention, a reactive telephone counseling a and an interactive web-based intervention and (as control) written self-help material.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational Interviewing (MI) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Structured Brief Advice (SBA) | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing (MI); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Structured Brief Advice (SBA); Assigned to Arm(s): 2
B: Arm Label: Enhanced PTSD Health Buddy and Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivation Interviewing Counseling | Arm Label: Usual PTSD Health Buddy Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivation Interviewing Counseling; Assigned to Arm(s): Enhanced PTSD Health Buddy and Motivational Interviewing
C: Arm Label: Telephone counselling; Type: EXPERIMENTAL; Interventions: Device: Standard 15-minute telephone counselling, Device: Proactive telephone counselling | Arm Label: Proactive telephone counselling; Type: EXPERIMENTAL; Interventions: Device: Proactive telephone counselling | Arm Label: web-based smoking cessation programme; Type: EXPERIMENTAL; Interventions: Device: Interactive web-based smoking cessation programme | Arm Label: Self-help material; Type: ACTIVE_COMPARATOR; Interventions: Device: Self-help material | Intervention Type: DEVICE; Name: Standard 15-minute telephone counselling; Assigned to Arm(s): Telephone counselling | Intervention Type: DEVICE; Name: Proactive telephone counselling; Assigned to Arm(s): Proactive telephone counselling, Telephone counselling | Intervention Type: DEVICE; Name: Interactive web-based smoking cessation programme; Assigned to Arm(s): web-based smoking cessation programme | Intervention Type: DEVICE; Name: Self-help material; Assigned to Arm(s): Self-help material
D: Arm Label: Brief Advice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Advice (BA) | Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing (MI) | Arm Label: Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education (HE) | Intervention Type: BEHAVIORAL; Name: Brief Advice (BA); Assigned to Arm(s): Brief Advice | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing (MI); Assigned to Arm(s): Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Health Education (HE); Assigned to Arm(s): Health Education

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Life Goals Collaborative Care to Improve Health Outcomes in Mental Disorders
Brief Summary: Persons with serious mental illness (SMI) are at increased risk of cardiovascular disease (CVD). The goals of this study are to test a treatment, Life Goals Collaborative Care to help promote health behavior change and improve mental health and physical health-related quality of life, as well as to get feedback from patients and providers on what is needed to help better coordinate the physical and mental health care of these patients.


Options:
A: Arm Label: Computerized CBT + Internet Support Group; Type: EXPERIMENTAL; Interventions: Behavioral: CCBT+ISG/Collaborative Care | Arm Label: Computerized CBT Alone; Type: EXPERIMENTAL; Interventions: Behavioral: CCBT/Collaborative Care | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CCBT+ISG/Collaborative Care; Assigned to Arm(s): Computerized CBT + Internet Support Group | Intervention Type: BEHAVIORAL; Name: CCBT/Collaborative Care; Assigned to Arm(s): Computerized CBT Alone
B: Arm Label: Arm 1 - Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Arm 2 - Life Goals Collaborative Care; Type: EXPERIMENTAL; Interventions: Behavioral: Life Goals Collaborative Care | Intervention Type: BEHAVIORAL; Name: Life Goals Collaborative Care; Assigned to Arm(s): Arm 2 - Life Goals Collaborative Care
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative depression care management | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced usual care | Intervention Type: BEHAVIORAL; Name: Collaborative depression care management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Enhanced usual care; Assigned to Arm(s): 2
D: Arm Label: A Helping Hand (AHH); Type: EXPERIMENTAL; Interventions: Behavioral: Self-care management | Arm Label: Usual Care (UC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-care management; Assigned to Arm(s): A Helping Hand (AHH)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Strengthening the Midwife Service Scheme With Community Focused Interventions: Evidence From a Randomized Controlled Field Trial in Nigeria
Brief Summary: The objective of this cluster randomized controlled trial is to assess the impact of several community-based interventions that address the key factors underlying the high maternal mortality, as well as neonatal mortality and morbidity in northern Nigeria. The interventions, include:

1. a Voluntary Health Worker Program (VHW)
2. the VHW program with provision of a safe birth kit
3. the VHW program with community folk media activities.


Options:
A: Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxytocin | Arm Label: carbetocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: carbetocin | Arm Label: misopristol; Type: ACTIVE_COMPARATOR; Interventions: Drug: misopristol | Intervention Type: DRUG; Name: carbetocin; Assigned to Arm(s): carbetocin | Intervention Type: DRUG; Name: misopristol; Assigned to Arm(s): misopristol | Intervention Type: DRUG; Name: oxytocin; Assigned to Arm(s): Oxytocin
B: Arm Label: Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Other: Misoprostol + referral | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo + referral | Intervention Type: OTHER; Name: Misoprostol + referral; Assigned to Arm(s): Misoprostol | Intervention Type: OTHER; Name: Placebo + referral; Assigned to Arm(s): Placebo
C: Arm Label: Voluntary Health Worker (VHW) Program; Type: EXPERIMENTAL; Interventions: Behavioral: Voluntary Health Worker (VHW) Program | Arm Label: VHW program plus Safe Birth Kit; Type: EXPERIMENTAL; Interventions: Behavioral: Voluntary Health Worker (VHW) Program, Behavioral: Safe Birth Kit | Arm Label: VHW program plus Folk Media Activities; Type: EXPERIMENTAL; Interventions: Behavioral: Voluntary Health Worker (VHW) Program, Behavioral: Community Folk Media Campaigns | Intervention Type: BEHAVIORAL; Name: Voluntary Health Worker (VHW) Program; Assigned to Arm(s): VHW program plus Folk Media Activities, VHW program plus Safe Birth Kit, Voluntary Health Worker (VHW) Program | Intervention Type: BEHAVIORAL; Name: Safe Birth Kit; Assigned to Arm(s): VHW program plus Safe Birth Kit | Intervention Type: BEHAVIORAL; Name: Community Folk Media Campaigns; Assigned to Arm(s): VHW program plus Folk Media Activities
D: Arm Label: misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): misoprostol

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IV, Randomized, Single Center, Parallel Group Trial of Human Fibrinogen Concentrate (Haemocomplettan) in the Treatment of Dilutional Coagulopathy During Major Pediatric Surgery
Brief Summary: The purpose of this study is to compare two different thromboelastometry (ROTEM) trigger levels for administration of human fibrinogen concentrate (Haemocomplettan P) in the treatment of perioperative dilutional coagulopathy during major pediatric surgery. The study hypothesis is that administration of fibrinogen concentrate triggered by a ROTEM FibTEM MCF \< 13 mm might reduce the total amount of transfused red cell concentrate during 24 hours after start of surgery as compared to a trigger level of ROTEM FibTEM MCF \< 8 mm.


Options:
A: Arm Label: Fibrinogen if FibTEM < 8 mm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Human fibrinogen concentrate | Arm Label: Fibrinogen if FibTEM < 13 mm; Type: EXPERIMENTAL; Interventions: Drug: Human fibrinogen concentrate | Intervention Type: DRUG; Name: Human fibrinogen concentrate; Assigned to Arm(s): Fibrinogen if FibTEM < 13 mm, Fibrinogen if FibTEM < 8 mm
B: Arm Label: Tranexamic acid; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Tranexamic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic acid | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo [Saline] | Intervention Type: DRUG; Name: Tranexamic acid; Assigned to Arm(s): Tranexamic acid | Intervention Type: DRUG; Name: Placebo [Saline]; Assigned to Arm(s): placebo
D: Arm Label: Albumin; Type: PLACEBO_COMPARATOR; Interventions: Drug: Human albumin (Placebo) | Arm Label: Haemocomplettan® P; Type: EXPERIMENTAL; Interventions: Drug: Haemocomplettan® P | Intervention Type: DRUG; Name: Haemocomplettan® P; Assigned to Arm(s): Haemocomplettan® P | Intervention Type: DRUG; Name: Human albumin (Placebo); Assigned to Arm(s): Albumin

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase IV, Randomized, Single Center, Parallel Group Trial of Human Fibrinogen Concentrate (Haemocomplettan) in the Treatment of Dilutional Coagulopathy During Major Pediatric Surgery
Brief Summary: The purpose of this study is to compare two different thromboelastometry (ROTEM) trigger levels for administration of human fibrinogen concentrate (Haemocomplettan P) in the treatment of perioperative dilutional coagulopathy during major pediatric surgery. The study hypothesis is that administration of fibrinogen concentrate triggered by a ROTEM FibTEM MCF \< 13 mm might reduce the total amount of transfused red cell concentrate during 24 hours after start of surgery as compared to a trigger level of ROTEM FibTEM MCF \< 8 mm.


Options:
A: Arm Label: coronary artery disease; Type: N/A; Interventions: N/A
B: Arm Label: POC algorithm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Point-of-Care versus conventional coagulation management | Arm Label: conventional algorithm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Point-of-Care versus conventional coagulation management | Intervention Type: PROCEDURE; Name: Point-of-Care versus conventional coagulation management; Assigned to Arm(s): POC algorithm, conventional algorithm
C: Arm Label: Clopidogrel+Aspirin, hypercoagulabel; Type: EXPERIMENTAL; Interventions: Drug: Clopidogrel+acetylsalicylic acid | Arm Label: Aspirin,hypercoagulabel control; Type: ACTIVE_COMPARATOR; Interventions: Drug: acetylsalicylic acid | Intervention Type: DRUG; Name: Clopidogrel+acetylsalicylic acid; Assigned to Arm(s): Clopidogrel+Aspirin, hypercoagulabel | Intervention Type: DRUG; Name: acetylsalicylic acid; Assigned to Arm(s): Aspirin,hypercoagulabel control
D: Arm Label: Fibrinogen if FibTEM < 8 mm; Type: ACTIVE_COMPARATOR; Interventions: Drug: Human fibrinogen concentrate | Arm Label: Fibrinogen if FibTEM < 13 mm; Type: EXPERIMENTAL; Interventions: Drug: Human fibrinogen concentrate | Intervention Type: DRUG; Name: Human fibrinogen concentrate; Assigned to Arm(s): Fibrinogen if FibTEM < 13 mm, Fibrinogen if FibTEM < 8 mm

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Study of the Use of Human Milk Cream as a Caloric Supplement in a Subset of Very Low Birth Weight Pre-Term Infants
Brief Summary: Human milk is commonly considered to have 20 calories per ounce (kcal/oz). However, studies show that up to 65% of human milk may be less than the expected 20 kcal/oz which can greatly affect an infant's growth. The investigators now have the ability to measure caloric density of human milk and add human milk cream to any human milk (mother's own or donor human milk) that is less than 20 kcal/oz to bring it up to that amount.


Options:
A: Arm Label: Intervention group; Type: OTHER; Interventions: Dietary Supplement: Addition of human milk fortifiers according to human milk analysis | Intervention Type: DIETARY_SUPPLEMENT; Name: Addition of human milk fortifiers according to human milk analysis; Assigned to Arm(s): Intervention group
B: Arm Label: High Dose Protein (Individualized); Type: EXPERIMENTAL; Interventions: Dietary Supplement: High Dose Protein (Individualized) | Arm Label: High Dose Protein (Standardized); Type: EXPERIMENTAL; Interventions: Dietary Supplement: High Dose Protein (Standardized) | Arm Label: Standard protein supplementation; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard Protein Supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: High Dose Protein (Individualized); Assigned to Arm(s): High Dose Protein (Individualized) | Intervention Type: DIETARY_SUPPLEMENT; Name: High Dose Protein (Standardized); Assigned to Arm(s): High Dose Protein (Standardized) | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard Protein Supplementation; Assigned to Arm(s): Standard protein supplementation
C: Arm Label: New human milk fortifier; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Human milk fortifier | Arm Label: Currently marketed fortifier; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Human milk fortifier | Arm Label: New human milk fortifier with new Ca source; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Human milk fortifier | Intervention Type: DIETARY_SUPPLEMENT; Name: Human milk fortifier; Assigned to Arm(s): Currently marketed fortifier, New human milk fortifier, New human milk fortifier with new Ca source
D: Arm Label: Human Milk Cream Group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Human Milk Cream | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Human Milk Cream; Assigned to Arm(s): Human Milk Cream Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Study of the Use of Human Milk Cream as a Caloric Supplement in a Subset of Very Low Birth Weight Pre-Term Infants
Brief Summary: Human milk is commonly considered to have 20 calories per ounce (kcal/oz). However, studies show that up to 65% of human milk may be less than the expected 20 kcal/oz which can greatly affect an infant's growth. The investigators now have the ability to measure caloric density of human milk and add human milk cream to any human milk (mother's own or donor human milk) that is less than 20 kcal/oz to bring it up to that amount.


Options:
A: Arm Label: Individualized fortification of breast milk; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Individualized fortification of breast milk | Intervention Type: DIETARY_SUPPLEMENT; Name: Individualized fortification of breast milk; Assigned to Arm(s): Individualized fortification of breast milk
B: Arm Label: High Dose Protein (Individualized); Type: EXPERIMENTAL; Interventions: Dietary Supplement: High Dose Protein (Individualized) | Arm Label: High Dose Protein (Standardized); Type: EXPERIMENTAL; Interventions: Dietary Supplement: High Dose Protein (Standardized) | Arm Label: Standard protein supplementation; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Standard Protein Supplementation | Intervention Type: DIETARY_SUPPLEMENT; Name: High Dose Protein (Individualized); Assigned to Arm(s): High Dose Protein (Individualized) | Intervention Type: DIETARY_SUPPLEMENT; Name: High Dose Protein (Standardized); Assigned to Arm(s): High Dose Protein (Standardized) | Intervention Type: DIETARY_SUPPLEMENT; Name: Standard Protein Supplementation; Assigned to Arm(s): Standard protein supplementation
C: Arm Label: Intervention group; Type: OTHER; Interventions: Dietary Supplement: Addition of human milk fortifiers according to human milk analysis | Intervention Type: DIETARY_SUPPLEMENT; Name: Addition of human milk fortifiers according to human milk analysis; Assigned to Arm(s): Intervention group
D: Arm Label: Human Milk Cream Group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Human Milk Cream | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Human Milk Cream; Assigned to Arm(s): Human Milk Cream Group

Answer: D